{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T03:39:31Z","timestamp":1778125171274,"version":"3.51.4"},"reference-count":0,"publisher":"Dustri-Verlgag Dr. Karl Feistle","issue":"09","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CN"],"published-print":{"date-parts":[[2014,9,1]]},"DOI":"10.5414\/cn108227","type":"journal-article","created":{"date-parts":[[2014,7,31]],"date-time":"2014-07-31T06:59:27Z","timestamp":1406789967000},"page":"191-201","source":"Crossref","is-referenced-by-count":9,"title":["Use of sevelamer to examine the role of intraluminal phosphate in the pathogenesis of secondary hyperparathyroidism"],"prefix":"10.5414","volume":"82","author":[{"given":"Kenneth R.","family":"Phelps","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim S.","family":"Stote","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darius","family":"Mason","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3374","container-title":["Clinical Nephrology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2014,7,31]],"date-time":"2014-07-31T06:59:27Z","timestamp":1406789967000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dustri.com\/article_response_page.html?artId=12549&doi=10.5414\/CN108227&L=0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,1]]},"references-count":0,"journal-issue":{"issue":"09","published-print":{"date-parts":[[2014]]}},"alternative-id":["108227"],"URL":"https:\/\/doi.org\/10.5414\/cn108227","relation":{},"ISSN":["0301-0430"],"issn-type":[{"value":"0301-0430","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9,1]]}}}